Translation and Validation of the French Version of Confusion Assessment Method for the Intensive Care Unit
Launched by UNIVERSITY HOSPITAL, MONTPELLIER · Apr 29, 2016
Trial Information
Current as of May 29, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult, \> or equal to 18-yr
- • Richmond Agitation Sedation Scale (RASS) \> or equal -3
- • Francophone
- Exclusion Criteria:
- • Diagnostic of cognitive disorders
- • Admission for brain injury
- • Psychotic disorders
- • Diagnostic of cognitive disorders
- • Visual or auditory impairments
About University Hospital, Montpellier
The University Hospital of Montpellier is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. Renowned for its commitment to patient-centered care, the hospital collaborates with multidisciplinary teams to explore cutting-edge treatments and therapies across various medical fields. By integrating clinical practice with education and research, the University Hospital of Montpellier aims to enhance health outcomes and contribute to the scientific community's understanding of complex medical conditions. Its robust infrastructure and expertise make it a pivotal player in the landscape of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Montpellier, Languedoc Roussillon, France
Patients applied
Trial Officials
GERALD CHANQUES, MD,Ph.D
Principal Investigator
University of Montpellier Hospitals
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials